More Island Pharmaceuticals Ltd news
Island Pharmaceuticals LtdASX: ILA

Island updates API agreement

Sep 20, 2021 at 12:30 AM EDT · Issued by Island Pharmaceuticals Ltd

Filed with ASX · Sep 20, 2021 at 12:30 AM EDT

On 6ix: 6ix.com/news/island-updates-api-agreement

Island Pharmaceuticals Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Island Pharmaceuticals Ltd on 6ix

Earlier from Island Pharmaceuticals

  • Griffith Uni Anti-Viral Molecule Screening CollaborationAug 22, 2021
  • Island granted key Australian patent for ISLA-101Aug 17, 2021
  • Island secures API - shortens timeline to clinical trialsJul 22, 2021
  • Island Pharmaceuticals granted key United States patentMay 18, 2021

Later from Island Pharmaceuticals

  • ISLA-101 Phase 2a clinical trial updateNov 8, 2021
  • Island executes PEACH clinical study CRO agreementJan 3, 2022
  • ISLA-101 manufacturing and timeline updateJun 15, 2022
  • ISLA-101 manufacturing progressOct 27, 2022
  • Positive analytical results for ISLA-101 capsulesNov 13, 2022
All Island Pharmaceuticals news releases↗

Follow Island Pharmaceuticals into a list and get an email when it puts out news.

Follow Island Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer